Latest Episodes
54
Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between...
53
Episode 53: Frank David, Founder and Managing Director, Pharmagellan
How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan...
52
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI
How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far...
51
Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio
How do you turn back the epigenetic clock for humans and their animal companions? Host Chris O'Brien welcomes Dan Oliver, CEO and Founder of...
50
Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova
Now on the Few & Far Between podcast: Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia?...
49
Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health
Today on the Biorasi Few & Far Between podcast: What if you could read a story before its official release? Competitive intelligence gives you...